WOMESH SAHADEO: Open Payments
NPI 1386625929 · WEST PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,255 in 195 payments from 14 companies in 2025. Trend: 2023 $3,894 · 2024 $3,836 · 2025 $4,255
Food & beverage: $4,144Education: $111
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 37 | $760 |
| Neurocrine BioSciences, Inc. | 23 | $526 |
| Teva Pharmaceuticals USA, Inc. | 17 | $417 |
| Otsuka America Pharmaceutical, Inc. | 22 | $413 |
| Vanda Pharmaceuticals Inc. | 15 | $359 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $339 |
| ABBVIE INC. | 15 | $328 |
| Axsome Therapeutics, Inc. | 14 | $326 |
| Alkermes, Inc. | 15 | $259 |
| Lundbeck LLC | 9 | $191 |
Products named: CAPLYTA, INGREZZA, REXULTI, TRINTELLIX, FANAPT, Auvelity, VRAYLAR, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
